These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31941542)

  • 21. Evaluation of DILI Predictive Hypotheses in Early Drug Development.
    Chan R; Benet LZ
    Chem Res Toxicol; 2017 Apr; 30(4):1017-1029. PubMed ID: 28257576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Model to predict severity of drug-induced liver injury in humans.
    Chen M; Borlak J; Tong W
    Hepatology; 2016 Sep; 64(3):931-40. PubMed ID: 27302180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-silico approach for drug induced liver injury prediction: Recent advances.
    Saini N; Bakshi S; Sharma S
    Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury.
    Kohonen P; Parkkinen JA; Willighagen EL; Ceder R; Wennerberg K; Kaski S; Grafström RC
    Nat Commun; 2017 Jul; 8():15932. PubMed ID: 28671182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep Learning for Drug-Induced Liver Injury.
    Xu Y; Dai Z; Chen F; Gao S; Pei J; Lai L
    J Chem Inf Model; 2015 Oct; 55(10):2085-93. PubMed ID: 26437739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Alternative Drug-Induced Liver Injury Classifications Using Molecular Descriptors, Gene Expression Perturbation, and Toxicology Reports.
    Lesiński W; Mnich K; Rudnicki WR
    Front Genet; 2021; 12():661075. PubMed ID: 34276771
    [No Abstract]   [Full Text] [Related]  

  • 27. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
    Aithal GP
    Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints.
    Kim E; Nam H
    BMC Bioinformatics; 2017 May; 18(Suppl 7):227. PubMed ID: 28617228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel cell-based assay for the evaluation of immune- and inflammatory-related gene expression as biomarkers for the risk assessment of drug-induced liver injury.
    Oda S; Matsuo K; Nakajima A; Yokoi T
    Toxicol Lett; 2016 Jan; 241():60-70. PubMed ID: 26546780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine Learning to Predict Drug-Induced Liver Injury and Its Validation on Failed Drug Candidates in Development.
    Mostafa F; Howle V; Chen M
    Toxics; 2024 May; 12(6):. PubMed ID: 38922065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting drug-induced liver injury in human with Naïve Bayes classifier approach.
    Zhang H; Ding L; Zou Y; Hu SQ; Huang HG; Kong WB; Zhang J
    J Comput Aided Mol Des; 2016 Oct; 30(10):889-898. PubMed ID: 27640149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays.
    Shah F; Leung L; Barton HA; Will Y; Rodrigues AD; Greene N; Aleo MD
    Toxicol Sci; 2015 Oct; 147(2):500-14. PubMed ID: 26206150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ResNet18DNN: prediction approach of drug-induced liver injury by deep neural network with ResNet18.
    Chen Z; Jiang Y; Zhang X; Zheng R; Qiu R; Sun Y; Zhao C; Shang H
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34882224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An entropy weight method to integrate big omics and mechanistically evaluate DILI.
    Jin Y; Shou Y; Lei Q; Du C; Xu L; Chen N; Ma W; Zhu X; Zhou S; Zheng Y; Yu D
    Hepatology; 2024 Jun; 79(6):1264-1278. PubMed ID: 37820269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CREB is a potential marker associated with drug-induced liver injury: Identification and validation through transcriptome database analysis.
    Zhang Q; Taniguchi S; So K; Tsuda M; Higuchi Y; Hashida M; Yamashita F
    J Toxicol Sci; 2022; 47(8):337-348. PubMed ID: 35922923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
    Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
    Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latest advances in diagnosing and predicting DILI: what was new in 2017?
    Barnhill MS; Real M; Lewis JH
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1033-1043. PubMed ID: 30111182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causality assessment in drug-induced liver injury.
    Hayashi PH
    Semin Liver Dis; 2009 Nov; 29(4):348-56. PubMed ID: 19826968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.